Clinical trial
Sotrovimab Expanded Access Treatment Protocol
NCT05235347 is registered in ClinicalTrials.gov with Vir Biotechnology, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sotrovimab Expanded Access Treatment Protocol
- Lead sponsor
- Vir Biotechnology, Inc.
- Phase
- Expanded access
- Overall status
- No longer available
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- Not reported
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
covid19